Back
Sunnova Energy International 10K Form
Buy
60
NOVA
Sunnova Energy International
Last Price:
7.07
Seasonality Move:
6.53%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-03-06 | 10K | NOVA/Sunnova Energy International Annual |
| 2020-02-25 | 10K | NOVA/Sunnova Energy International Annual |
| 2019-10-31 | 10Q | NOVA/Sunnova Energy International Quarterly |
| 2019-08-19 | 10Q | NOVA/Sunnova Energy International Quarterly |
Receive NOVA News And Ratings
See the #1 stock for the next 7 days that we like better than NOVA
NOVA Financial Statistics
Sales & Book Value
| Annual Sales: | $720.65M |
|---|---|
| Cash Flow: | $-559.01M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $14.24 |
| Price / Book: | 0.5 |
Profitability
| EPS (TTM): | -3.38000 |
|---|---|
| Net Income (TTM): | $-413.24M |
| Gross Margin: | $293.16M |
| Return on Equity: | -17.2% |
| Return on Assets: | -3.48% |
Sunnova Energy International Earnings Forecast
Key Sunnova Energy International Financial Ratios
- The Gross Profit Margin over the past 7 years for NOVA is 40.68%.
- The Selling, General & Administrative Expenses for NOVA have been equal to 59.73% of Gross Profit Margin.
- The Interest Expense is -88.99% of Operating Income.
- The Net Earning history of NOVA is -58.00% of Total Revenues.
- Per Share Earnings over the last 7 years have been positive in 2 years.
Sunnova Energy International Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Independent Power & Renewable Electricity Producer |
| Sector: | Utilities |
| Current Symbol: | NOVA |
| Website: | sunnova.com |
Debt
| Debt-to-Equity Ratio: | 4.63 |
|---|---|
| Current Ratio: | 0.86 |
| Quick Ratio: | 0.69 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NOVA Technical Analysis vs Fundamental Analysis
Buy
60
Sunnova Energy International (NOVA)
is a Buy
Is Sunnova Energy International a Buy or a Sell?
-
Sunnova Energy International stock is rated a Buy
The current Sunnova Energy International [NOVA] share price is $7.06. The Score for NOVA is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.